Location History:
- Boulder, CO (US) (2017 - 2019)
- Louisville, CO (US) (2018 - 2019)
Company Filing History:
Years Active: 2017-2019
Title: Aimee Jackson: Innovator in Oligonucleotide Therapeutics
Introduction
Aimee Jackson is a prominent inventor based in Boulder, Colorado. She has made significant contributions to the field of oligonucleotide therapeutics, holding a total of five patents. Her work focuses on innovative methods for treating various cancers and promoting wound healing.
Latest Patents
Among her latest patents is the invention of oligonucleotide compositions that inhibit miR-155. This invention provides methods for treating cancers, such as T cell lymphoma, by administering oligonucleotide inhibitors. Additionally, she has developed methods for reducing the proliferation of malignant T cells through these inhibitors. Another notable patent involves miR-92 inhibitors, which offer methods for evaluating the efficacy of therapeutics aimed at promoting wound healing.
Career Highlights
Aimee Jackson has established herself as a key figure in her field through her innovative research and patent contributions. Her work has the potential to impact cancer treatment and regenerative medicine significantly.
Collaborations
Aimee collaborates with talented individuals such as Anita Seto and Christina Marie Dalby, enhancing the research and development efforts at her company.
Conclusion
Aimee Jackson's contributions to oligonucleotide therapeutics exemplify her dedication to advancing medical science. Her innovative patents and collaborative efforts position her as a leading inventor in her field.